Imatinib and beyond - the new CML study IV: A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2004
|
| In: |
Annals of hematology
Year: 2004, Jahrgang: 83, Heft: 4, Pages: 258-264 |
| ISSN: | 1432-0584 |
| DOI: | 10.1007/s00277-003-0807-x |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00277-003-0807-x
|
| Verfasserangaben: | U. Berger, G. Engelich, A. Reiter, A. Hochhaus, R. Hehlmann, The German CML Study Group |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 180167101X | ||
| 003 | DE-627 | ||
| 005 | 20220820182038.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220512s2004 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00277-003-0807-x |2 doi | |
| 035 | |a (DE-627)180167101X | ||
| 035 | |a (DE-599)KXP180167101X | ||
| 035 | |a (OCoLC)1341459962 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Berger, Ute |e VerfasserIn |0 (DE-588)1255399929 |0 (DE-627)1799635341 |4 aut | |
| 245 | 1 | 0 | |a Imatinib and beyond - the new CML study IV |b A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia |c U. Berger, G. Engelich, A. Reiter, A. Hochhaus, R. Hehlmann, The German CML Study Group |
| 264 | 1 | |c 2004 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published: 29 November 2003 | ||
| 500 | |a Gesehen am 12.05.2022 | ||
| 650 | 4 | |a Chronic myeloid leukemia | |
| 650 | 4 | |a Clinical trial | |
| 650 | 4 | |a Imatinib | |
| 650 | 4 | |a Interferon alpha | |
| 650 | 4 | |a Stem cell transplantation | |
| 700 | 1 | |a Engelich, G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Reiter, Andreas |d 1964- |e VerfasserIn |0 (DE-588)172629551 |0 (DE-627)697563766 |0 (DE-576)133488594 |4 aut | |
| 700 | 1 | |a Hochhaus, Andreas |d 1959- |e VerfasserIn |0 (DE-588)1107039339 |0 (DE-627)863321976 |0 (DE-576)474976130 |4 aut | |
| 700 | 1 | |a Hehlmann, Rüdiger |d 1941- |e VerfasserIn |0 (DE-588)1037003489 |0 (DE-627)751737879 |0 (DE-576)390939463 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of hematology |d Berlin : Springer, 1991 |g 83(2004), 4, Seite 258-264 |h Online-Ressource |w (DE-627)253389852 |w (DE-600)1458429-3 |w (DE-576)072283157 |x 1432-0584 |7 nnas |a Imatinib and beyond - the new CML study IV A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia |
| 773 | 1 | 8 | |g volume:83 |g year:2004 |g number:4 |g pages:258-264 |g extent:7 |a Imatinib and beyond - the new CML study IV A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00277-003-0807-x |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220512 | ||
| 993 | |a Article | ||
| 994 | |a 2004 | ||
| 998 | |g 1037003489 |a Hehlmann, Rüdiger |m 1037003489:Hehlmann, Rüdiger |d 60000 |d 61200 |e 60000PH1037003489 |e 61200PH1037003489 |k 0/60000/ |k 1/60000/61200/ |p 5 |y j | ||
| 998 | |g 1107039339 |a Hochhaus, Andreas |m 1107039339:Hochhaus, Andreas |d 60000 |d 61200 |e 60000PH1107039339 |e 61200PH1107039339 |k 0/60000/ |k 1/60000/61200/ |p 4 | ||
| 998 | |g 172629551 |a Reiter, Andreas |m 172629551:Reiter, Andreas |d 60000 |d 61200 |e 60000PR172629551 |e 61200PR172629551 |k 0/60000/ |k 1/60000/61200/ |p 3 | ||
| 998 | |g 1255399929 |a Berger, Ute |m 1255399929:Berger, Ute |d 60000 |d 61200 |e 60000PB1255399929 |e 61200PB1255399929 |k 0/60000/ |k 1/60000/61200/ |p 1 |x j | ||
| 999 | |a KXP-PPN180167101X |e 4133247000 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","given":"Ute","display":"Berger, Ute","family":"Berger"},{"role":"aut","given":"G.","display":"Engelich, G.","family":"Engelich"},{"role":"aut","given":"Andreas","family":"Reiter","display":"Reiter, Andreas"},{"role":"aut","given":"Andreas","display":"Hochhaus, Andreas","family":"Hochhaus"},{"display":"Hehlmann, Rüdiger","family":"Hehlmann","role":"aut","given":"Rüdiger"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Imatinib and beyond - the new CML study IV","subtitle":"A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia","title_sort":"Imatinib and beyond - the new CML study IV"}],"origin":[{"dateIssuedDisp":"2004","dateIssuedKey":"2004"}],"note":["Published: 29 November 2003","Gesehen am 12.05.2022"],"id":{"doi":["10.1007/s00277-003-0807-x"],"eki":["180167101X"]},"physDesc":[{"extent":"7 S."}],"name":{"displayForm":["U. Berger, G. Engelich, A. Reiter, A. Hochhaus, R. Hehlmann, The German CML Study Group"]},"relHost":[{"id":{"eki":["253389852"],"issn":["1432-0584"],"zdb":["1458429-3"]},"recId":"253389852","physDesc":[{"extent":"Online-Ressource"}],"disp":"Imatinib and beyond - the new CML study IV A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemiaAnnals of hematology","type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["62, 1 (Februrary 1991)-"],"origin":[{"publisherPlace":"Berlin ; Heidelberg ; New York","dateIssuedKey":"1991","publisher":"Springer","dateIssuedDisp":"1991-"}],"note":["Gesehen am 24.04.2025","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 80.2001: Supplement"],"title":[{"title":"Annals of hematology","title_sort":"Annals of hematology","subtitle":"organ of: Gesellschaft für Thrombose- und Hämostaseforschung, DGHO, Deutsche Gesellschaft für Hämatologie und Onkologie e.V., ÖGHO, Österreichische Gesellschaft für Hämatologie und Onkologie"}],"part":{"pages":"258-264","year":"2004","text":"83(2004), 4, Seite 258-264","issue":"4","volume":"83","extent":"7"},"titleAlt":[{"title":"Hematology"}],"language":["eng"]}],"recId":"180167101X"} | ||
| SRT | |a BERGERUTEEIMATINIBAN2004 | ||